Academic Journal

1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

التفاصيل البيبلوغرافية
العنوان: 1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3
المؤلفون: Sulkowski, M., Gardiner, D., Lawitz, E., Hinestrosa, F., Nelson, D., Thuluvath, P., Rodriguez-Torres, M., Lok, A., Schwartz, H., Reddy, K.R., Eley, T., Wind-Rotolo, M., Huang, S.-P., Gao, M., McPhee, F., Hindes, R., Symonds, B., Pasquinelli, C., Grasela, D.
المصدر: Journal of Hepatology ; volume 56, page S560 ; ISSN 0168-8278
بيانات النشر: Elsevier BV
سنة النشر: 2012
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s0168-8278(12)61433-0
الاتاحة: http://dx.doi.org/10.1016/s0168-8278(12)61433-0
https://api.elsevier.com/content/article/PII:S0168827812614330?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0168827812614330?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/
رقم الانضمام: edsbas.38588F97
قاعدة البيانات: BASE
الوصف
DOI:10.1016/s0168-8278(12)61433-0